Everence Capital Management’s Exact Sciences EXAS Stock Holding History

Everence Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,540	Closed	-$563K	–	830
2025 Q4	$563K	Hold	5,540	–	–	0.03%	356
2025 Q3	$303K	Hold	5,540	–	–	0.02%	605
2025 Q2	$294K	Hold	5,540	–	–	0.02%	593
2025 Q1	$240K	Sell	5,540 -790	-12%	-$40K	0.02%	665
2024 Q4	$356K	Buy	+6,330	New	+$394K	0.02%	494

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Everence Capital Management's EXAS Position: Q1 2026 in Review

Everence Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,540 shares — an estimated $563K sold.

Everence Capital Management first reported a position in EXAS in Q4 2024 and held it in 5 quarters. The position peaked at $563K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

Everence Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
Everence Capital Management sold 5,540 Exact Sciences shares in Q1 2026, an estimated $563K.
Everence Capital Management first reported a position in Exact Sciences in Q4 2024 and held it in 5 quarters.
Everence Capital Management's Exact Sciences position peaked at $563K in Q4 2025.
6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.